Effect of dietary protein restriction and angiotensin converting enzyme inhibition on protein metabolism in the nephrotic syndrome.
Don
B R
BR
Medical Service, San Francisco General Hospital Medical Center, California.
Wada
L
L
Kaysen
G A
GA
Schambelan
M
M
D000596:Amino Acids / Q000097:blood; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001806:Blood Urea Nitrogen; D003404:Creatinine / Q000097:blood; D004044:Dietary Proteins / Q000008:administration & dosage* / Q000627:therapeutic use; D004656:Enalapril / Q000627:therapeutic use*; D006801:Humans; D009404:Nephrotic Syndrome / Q000097:blood / Q000378:metabolism*; D011506:Proteins / Q000378:metabolism*
D000596:Amino Acids; D000806:Angiotensin-Converting Enzyme Inhibitors; D004044:Dietary Proteins; D011506:Proteins; D004656:Enalapril; D003404:Creatinine